Progyny Q1 Fertility Benefits Revenue Up 24% with $75M Buyback
Progyny’s Q1 fertility benefits revenue rose 24% year over year to $74.5 million, driven by the addition of 20 new corporate clients. The board also approved a $75 million share repurchase program to bolster earnings per share.
1. Q1 Financial Results
Progyny delivered fertility benefits revenue of $74.5 million in Q1, up 24% from a year earlier, fueled by signing 20 new employer clients and expanding plan enrollments.
2. $75M Share Repurchase Plan
The board authorized up to $75 million in stock repurchases over the next 12 months, representing roughly 5% of outstanding shares, to support adjusted EPS.
3. Strategic Expansion
Management highlighted ongoing investments in digital health tools and partnerships with self-insured employers to sustain double-digit benefits utilization growth.
4. Shareholder Value Focus
Executives emphasized the buyback’s role in enhancing returns for investors and reaffirmed commitment to achieving profitability and positive free cash flow.